These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3308617)

  • 1. [Vidarabine treatment of chronic active hepatitis associated with hepatitis B virus multiplication. A randomized multicenter study].
    Ouzan D; Degos F; Marcellin P; Linberg J; Chevallier M; Degott C; Bréchot C; Chossegros P; Weiss AM; Hirtz J
    Gastroenterol Clin Biol; 1987; 11(8-9):568-73. PubMed ID: 3308617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HBe antigen and B virus DNA in patients with chronic active hepatitis].
    Chaussade S; Thiers V; Boboc B; Housset C; Bréchot C; Degos F
    Gastroenterol Clin Biol; 1986 Nov; 10(11):744-7. PubMed ID: 3803809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 3-year clinical trial of lamivudine in treatment of patients with chronic hepatitis B.
    Yao GB; Cui ZY; Wang BE; Yao JL; Zeng MD
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):188-93. PubMed ID: 15138107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of adenine arabinoside 5'-monophosphate in kidney transplant recipients with chronic active hepatitis B.
    Pol S; Saltiel C; Legendre C; Carnot F; Driss F; Berthelot P; Bréchot C; Ruet C; Kreis H
    Nephrol Dial Transplant; 1994; 9(7):820-3. PubMed ID: 7526277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permanent inhibition of viral replication induced by low dosage of human leukocyte interferon in patients with chronic hepatitis B.
    Pastore G; Santantonio T; Monno L; Milella M; Luchena N; Angarano G
    Hepatogastroenterology; 1988 Apr; 35(2):57-61. PubMed ID: 3371847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of immunotherapy with vaccination against hepatitis B virus on virus B multiplication].
    Pol S; Driss F; Carnot F; Michel ML; Berthelot P; Brechot C
    C R Acad Sci III; 1993 Jul; 316(7):688-91. PubMed ID: 8019891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S
    Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
    Buti M; Jardi R; Rodriguez-Frias F; Allende H; Cotrina M; Esteban R; Guardia J
    J Med Virol; 1996 Aug; 49(4):325-8. PubMed ID: 8877766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of chronic hepatitis B. Part 2: Effect of glycyrrhizic acid on the course of illness].
    Eisenburg J
    Fortschr Med; 1992 Jul; 110(21):395-8. PubMed ID: 1516877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized double-blind placebo-controlled study of lamivudine in the treatment of patients with chronic hepatitis B virus infection.
    Yao G; Wang B; Cui Z; Yao J; Zeng M
    Chin Med J (Engl); 1999 May; 112(5):387-91. PubMed ID: 11593504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients--a pilot study.
    Krastev Z; Jelev D; Antonov K; Alagozian V; Kotzev I
    Hepatogastroenterology; 1999; 46(30):3184-8. PubMed ID: 10626183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of low molecular weight glycoproteins in chronic hepatitis B.
    Vassilev M; Antonov K; Theocharov P; Krastev Z
    Hepatogastroenterology; 1996; 43(10):882-6. PubMed ID: 8884308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
    Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
    Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial.
    Bahrami H; Daryani NE; Haghpanah B; Moayyeri A; Moghadam KF; Mirmomen S; Kamangar F
    Am J Gastroenterol; 2005 Apr; 100(4):856-61. PubMed ID: 15784032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B.
    Lim SG; Ng TM; Kung N; Krastev Z; Volfova M; Husa P; Lee SS; Chan S; Shiffman ML; Washington MK; Rigney A; Anderson J; Mondou E; Snow A; Sorbel J; Guan R; Rousseau F;
    Arch Intern Med; 2006 Jan; 166(1):49-56. PubMed ID: 16401810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic activity of vidarabine in symptomatic chronic active hepatitis related to HBV.
    Trépo C; Ouzan D; Fontanges T; Chevallier M; Chossegros P; Degos F; Chevallier P; Hantz O
    J Hepatol; 1986; 3 Suppl 2():S97-105. PubMed ID: 2439581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
    Hoofnagle JH; Hanson RG; Minuk GY; Pappas SC; Schafer DF; Dusheiko GM; Straus SE; Popper H; Jones EA
    Gastroenterology; 1984 Jan; 86(1):150-7. PubMed ID: 6196251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.